• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23378 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     Health Quality Ontario (HQO) Sodium restriction in heart failure: a rapid review
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sodium thiosulfate for prevention of hearing loss in children receiving cisplatin chemotherapy
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sodium valproate (Episenta®)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sodium zirconium cyclosilicate for hyperkalaemia – first line
2022     Agency for Care Effectiveness (ACE) Sodium zirconium cyclosilicate for treating hyperkalaemia
2019     National Institute for Health and Care Excellence (NICE) Sodium zirconium cyclosilicate for treating hyperkalaemia. NICE technology appraisal guidance 599
2020     Agency for Care Effectiveness (ACE) Sodium-glucose co-transporter 2 (SGLT2) inhibitors for type 2 diabetes mellitus
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sofosbuvir (Sovaldi — Gilead Sciences Canada, Inc.) indication: chronic hepatitis C infection
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir (Sovaldi) with GS-5816 for chronic hepatitis C
2012     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir for chronic hepatitis C infection with compensated liver disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sofosbuvir for the treatment of patients with genotype 4 hepatitis C: a review of the clinical efficacy, cost-effectiveness, and guidelines
2014     NIHR Health Technology Assessment programme Sofosbuvir for treating chronic hepatitis C
2015     National Institute for Health and Care Excellence (NICE) Sofosbuvir for treating chronic hepatitis C. NICE technology appraisal guidance 330
2013     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir with ledipasvir for hepatitis C, genotype 1
2016     HAYES, Inc. Sofosbuvir-velpatasvir for chronic HCV infection
2017     National Institute for Health and Care Excellence (NICE) Sofosbuvir-velpatasvir for treating chronic hepatitis C. NICE technology appraisal guidance 430
2018     National Institute for Health and Care Excellence (NICE) Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C. NICE technology appraisal guidance 507
2016     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir, GS-9857 and velpatasvir triple therapy for chronic hepatitis C
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Soft tissue augmentation for HIV patients with lipodystrophy syndrome
2007     National Institute for Health and Care Excellence (NICE) Soft-palate implants for obstructive sleep apnoea. NICE interventional procedures guidance 241
2007     National Institute for Health and Care Excellence (NICE) Soft-palate implants for simple snoring. NICE interventional procedures guidance 240
2014     NIHR Horizon Scanning Centre (NIHR HSC) SoftVue™ system for diagnostic breast imaging
2024     NIHR Health Technology Assessment programme Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis
2005     Adelaide Health Technology Assessment (AHTA) Solar Scan (R) for the detection and monitoring of melanoma
2014     HAYES, Inc. Solesta (NASHA Dx; Q-Med AB) for treatment of fecal incontinence
2013     HAYES, Inc. Solesta (Q-Med AB) for treatment of fecal incontinence
2012     HAYES, Inc. Solesta (Q-Med AB) for treatment of fecal incontinence
2010     Medical Advisory Secretariat (MAS) Solid organ transplantation for End Stage Organ Failure (ESOF) in persons with HIV
2018     Agency for Care Effectiveness (ACE) Solifenacin for treating overactive bladder
2021     European Network for Health Technology Assessment (EUnetHTA) Solnatide for the treatment of COVID-19
2022     National Institute for Health and Care Excellence (NICE) Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy. NICE technology appraisal guidance 758
2022     National Institute for Health and Care Excellence (NICE) Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea. NICE technology appraisal guidance 777
2023     Health Technology Wales (HTW) Solution-focused assessment tools for improving the treatment of people with psychosis and schizophrenia within secondary mental health services
1999     University HealthSystem Consortium (UHC) Solvent/detergent-treated plasma
1999     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Somatic gene therapy: striking to the roots of disease (Short version of the TA study 'Gene therapy')
2006     HAYES, Inc. Somatosensory evoked potentials (SEPs) for intraoperative monitoring (IOM) during surgery for scoliosis
2012     HAYES, Inc. Somatosensory evoked potentials (SEPs) for intraoperative monitoring during spinal cord surgery for trauma or tumors
2006     HAYES, Inc. Somatosensory evoked potentials for prognosis of coma following cardiac arrest
2006     HAYES, Inc. Somatostatin receptor scintigraphy (SRS) for localization of neuroendocrine tumors and their metastases
1996     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Somatostatin receptor scintigraphy (systematic review, expert panel)
2023     National Institute for Health and Care Excellence (NICE) Somatrogon for treating growth disturbance in children and young people aged 3 years and over. NICE technology appraisal guidance 863
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: growth hormone deficiency in adults
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: Turner syndrome
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin for short stature
2017     Agency for Care Effectiveness (ACE) Somatropin for the treatment of growth failure in children
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Somnoplasty (R) system
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sonata™ System for the removal of uterine fibroids
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Sonographic diagnosis of acute abdomen in children and adults
2015     HAYES, Inc. Sonohysterography for assessment of abnormal uterine bleeding
2005     Adelaide Health Technology Assessment (AHTA) SonoPrep (R) Ultrasonic Skin Permeation system for skin preparation prior to cutaneous penetration
2005     New Zealand Health Technology Assessment (NZHTA) SonoPrep ultrasonic skin permeation system
2007     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for advanced non-small cell lung cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for hepatocellular carcinoma - adjuvant therapy
2007     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for hepatocellular carcinoma: horizon scanning technology briefing
2011     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) in combination with capecitabine for HER2-negative locally advanced or metastatic breast cancer - second line
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sorafenib (Nexavar®)
2006     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib for advanced hepatocellular carcinoma (HCC): horizon scanning review
2010     NIHR Health Technology Assessment programme Sorafenib for the treatment of advanced hepatocellular carcinoma
2010     National Institute for Health and Care Excellence (NICE) Sorafenib for the treatment of advanced hepatocellular carcinoma
2017     National Institute for Health and Care Excellence (NICE) Sorafenib for treating advanced hepatocellular carcinoma. NICE technology appraisal guidance 474
2006     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib tosylate (nexavar) for advanced renal cell carcinoma: horizon scanning review
2019     European Network for Health Technology Assessment (EUnetHTA) Sotagliflozin indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy
2020     National Institute for Health and Care Excellence (NICE) Sotagliflozin with insulin for treating type 1 diabetes. NICE technology appraisal guidance 622
2022     National Institute for Health and Care Excellence (NICE) Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer. NICE technology appraisal guidance 781
2011     NIHR Horizon Scanning Centre (NIHR HSC) Soundbite hearing system
2014     HAYES, Inc. SoundBite hearing system (Sonitus Medical Inc.) for treatment of unilateral hearing loss
2023     Agency for Care Effectiveness (ACE) SpaceOAR systems for rectum protection during prostate cancer treatment
2014     NIHR Horizon Scanning Centre (NIHR HSC) SpaceOAR® perirectal spacing system for prostate cancer radiation
2012     NIHR Horizon Scanning Centre (NIHR HSC) Spartan RX™ point-of-care DNA test for identifying the CYP2C19*2 mutation
2022     Institute for Clinical and Economic Review (ICER) Special assessment of outpatient treatments for COVID-19
1992     U. S. Congress. Office of Technology Assessment (OTA) Special care units for people with Alzheimer's and other dementias: consumer education, research, regulatory and reimbursement issues
2008     Blue Cross Blue Shield Association (BCBS) Special report: aCGH for the genetic evaluation of patients with developmental delay/mental retardation or autism spectrum disorder
2007     Blue Cross Blue Shield Association (BCBS) Special report: cardiovascular pharmacogenomics
2015     Blue Cross Blue Shield Association (BCBS) Special report: chromosomal microarray for the genetic evaluation of patients with global developmental delay, intellectual disability, and autism spectrum disorder
2012     Blue Cross Blue Shield Association (BCBS) Special report: chronic noncancer pain—long-term opioid benefits and harms
2011     Blue Cross Blue Shield Association (BCBS) Special report: companion diagnostics: example of BRAF gene mutation testing to select patients with melanoma for treatment with BRAF kinase inhibitors
2009     Blue Cross Blue Shield Association (BCBS) Special report: critical appraisal of CT colonography cost-effectiveness analyses
2005     Blue Cross Blue Shield Association (BCBS) Special report: current and evolving strategies in the treatment of age-related macular degeneration
2015     Blue Cross Blue Shield Association (BCBS) Special report: early intensive behavioral intervention and other behavioral interventions for autism spectrum disorder
2008     Blue Cross Blue Shield Association (BCBS) Special report: early intensive behavioral intervention based on applied behavior analysis among children with autism spectrum disorders
2003     Blue Cross Blue Shield Association (BCBS) Special report: Evidence on sequencing of conventional and biological disease-modifying anti-rheumatic drugs
2013     Blue Cross Blue Shield Association (BCBS) Special Report: exome sequencing for clinical diagnosis of patients with suspected genetic disorders
2006     Blue Cross Blue Shield Association (BCBS) Special report: fecal DNA analysis for colon cancer screening
2004     Blue Cross Blue Shield Association (BCBS) Special Report: Genotyping for cytochrome p450 polymorphisms to determine drug-metabolizer status
2003     Blue Cross Blue Shield Association (BCBS) Special report: high-sensitivity C-reactive protein measurement for coronary heart disease risk stratification
2006     Blue Cross Blue Shield Association (BCBS) Special report: intensity-modulated radiation therapy for cancer of the breast or lung
2003     Blue Cross Blue Shield Association (BCBS) Special report: Interventions to improve patient adherence with medications for chronic cardiovascular disorders
2005     Blue Cross Blue Shield Association (BCBS) Special report: intra-articular hyaluronan for osteoarthritis of the knee
2009     Blue Cross Blue Shield Association (BCBS) Special report: laboratory testing to allow area under the curve (AUC) - targeted 5-Fluorouracil dosing for patients administered chemotherapy for cancer
2011     Blue Cross Blue Shield Association (BCBS) Special report: maintenance therapy in advanced non-small-cell lung cancer
2006     Blue Cross Blue Shield Association (BCBS) Special report: measuring and reporting pain outcomes in randomized controlled trials
2014     Blue Cross Blue Shield Association (BCBS) Special report: medication adherence
2008     Blue Cross Blue Shield Association (BCBS) Special report: MEG and MSI for the purpose of presurgical localization of epileptic lesions - a challenge for technology evaluation
2013     Blue Cross Blue Shield Association (BCBS) Special Report: multiple molecular testing of cancers to identify targeted therapies
2007     Blue Cross Blue Shield Association (BCBS) Special report: pharmacogenomics of cancer-candidate genes
2010     Blue Cross Blue Shield Association (BCBS) Special report: positron emission tomography for the indication of post-treatment surveillance of cancer
2008     Blue Cross Blue Shield Association (BCBS) Special report: recent developments in prostate cancer genetics and genetic testing
2006     Blue Cross Blue Shield Association (BCBS) Special report: recombinant activated factor VII for uncontrolled bleeding in non-hemophiliac patients
2014     Blue Cross Blue Shield Association (BCBS) Special report: screening asymptomatic women with dense breasts and normal mammograms for breast cancer